Oliger Christy J. has filed 11 insider transactions across 5 companies since May 2023.
Most recent transaction: a disposition of 33390 shares of LAVA Therapeutics NV ($LVTX) on November 13, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 13, 2025 | LAVA Therapeutics NV | $LVTX | Oliger Christy J. | Not found | D | Share Options (Right to Buy) | 33390 | $0.00 | 0.0000 | 26,899,122 | 100.00% | 0.12% |
| June 18, 2025 | Nuvalent, Inc. | $NUVL | Oliger Christy J. | Not found | A | Class A Common Stock | 3971 | $0.00 | 3,971.0000 | 66,408,807 | 9999.99% | 0.01% |
| June 18, 2025 | Nuvalent, Inc. | $NUVL | Oliger Christy J. | Not found | A | Stock Option (Right to Buy) | 6119 | $0.00 | 6,119.0000 | 66,408,807 | 9999.99% | 0.01% |
| May 28, 2025 | Karyopharm Therapeutics Inc. | $KPTI | Oliger Christy J. | Not found | A | Nonstatutory Stock Option (right to buy) | 4600 | $0.00 | 4,600.0000 | 126,240,054 | 9999.99% | 0.00% |
| May 14, 2025 | Vera Therapeutics, Inc. | $VERA | Oliger Christy J. | Not found | A | Stock Option (right to buy) | 14000 | $0.00 | 14,000.0000 | 63,748,290 | 9999.99% | 0.02% |
| April 1, 2025 | Replimune Group, Inc. | $REPL | Oliger Christy J. | Director | A | Stock Option (right to buy) | 32000 | $0.00 | 32,000.0000 | 80,564,147 | 9999.99% | 0.04% |
| Feb. 13, 2025 | LAVA Therapeutics NV | $LVTX | Oliger Christy J. | Not found | A | Common Shares (Right to Buy) | 33390 | $0.00 | 33,390.0000 | 26,834,422 | 9999.99% | 0.12% |
| June 7, 2024 | Vera Therapeutics, Inc. | $VERA | Oliger Christy J. | Not found | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| May 29, 2024 | Karyopharm Therapeutics Inc. | $KPTI | Oliger Christy J. | Not found | A | Nonstatutory Stock Option (right to buy) | 69000 | $0.00 | 69,000.0000 | 0 | 9999.99% | 0.00% |
| April 1, 2024 | Replimune Group, Inc. | $REPL | Oliger Christy J. | Director | A | Stock Option (right to buy) | 32000 | $0.00 | 32,000.0000 | 66,569,894 | 9999.99% | 0.05% |
| May 24, 2023 | Karyopharm Therapeutics Inc. | $KPTI | Oliger Christy J. | Director | A | Nonstatutory Stock Option (right to buy) | 34000 | $0.00 | 34,000.0000 | 0 | 9999.99% | 0.00% |